Search research articles
Contact Us
Filters
Showing results (811-820 of 911) with videos related to
Page
of 92
Sort By:
Journal of the American College of Cardiology
|
April 22, 2026
Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percuatenous Coronary Intervention: ORBITA-2
Kayla Chiew, Michael J Foley, Shayna Chotai, et al.
The Journal of Biological Chemistry
|
June 27, 1997
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B
T A Berkhout, H M Sarau, K Moores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
Patricia L Podolin, Brian J Bolognese, James J Foley, et al.
BMJ Open
|
January 24, 2019
Silent cerebral infarction and cognitive function following TAVI: an observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve
Tarique Al Musa, Akhlaque Uddin, Catherine Loveday, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 28, 2024
Chemical and spectroscopic characterization of plutonium tetrafluoride
Jared S Kinyon, Eliel Villa-Aleman, Elodia Ciprian, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines
Brian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 5, 2017
Comparison of fast acquisition strategies in whole-heart four-dimensional flow cardiac MR: Two-center, 1.5 Tesla, phantom and in vivo validation study
Pankaj Garg, Jos J M Westenberg, Pieter J van den Boogaard, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2008
Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists
Yonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
Michael Salmon, Mark A Luttmann, James J Foley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist
H M Sarau, D E Griswold, B Bush, et al.
Page
of 92
Search research articles
Search
Showing results (811-820 of 911) with videos related to
Sort By:
Page
of 92
Journal of the American College of Cardiology
|
April 22, 2026
Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percuatenous Coronary Intervention: ORBITA-2
Kayla Chiew, Michael J Foley, Shayna Chotai, et al.
The Journal of Biological Chemistry
|
June 27, 1997
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B
T A Berkhout, H M Sarau, K Moores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
Patricia L Podolin, Brian J Bolognese, James J Foley, et al.
BMJ Open
|
January 24, 2019
Silent cerebral infarction and cognitive function following TAVI: an observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve
Tarique Al Musa, Akhlaque Uddin, Catherine Loveday, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 28, 2024
Chemical and spectroscopic characterization of plutonium tetrafluoride
Jared S Kinyon, Eliel Villa-Aleman, Elodia Ciprian, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines
Brian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 5, 2017
Comparison of fast acquisition strategies in whole-heart four-dimensional flow cardiac MR: Two-center, 1.5 Tesla, phantom and in vivo validation study
Pankaj Garg, Jos J M Westenberg, Pieter J van den Boogaard, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2008
Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists
Yonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
Michael Salmon, Mark A Luttmann, James J Foley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist
H M Sarau, D E Griswold, B Bush, et al.
Page
of 92